NCT03841266

Recurrence Risk Evaluation by 21-gene Detection

Postoperative Recurrence Risk Evaluation of Hormone Receptor Positive, Her-2 Negative Breast Cancer by Using Different 21-gene Detection Kits (REBCK)

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 220 (actual)
• Sponsor: Xijing Hospital · Academic / Other
• Sex: Female
• Age: 18 Years – 70 Years
• Healthy volunteers: —

Summary

Breast cancer patients with early breast cancer were enrolled according to the inclusion criteria. Baseline characteristics were recorded from medical record system. Recurrence score were obtained by 21-gene detection kits from different biological companies. Relationship between recurrence score and the prognosis was explored. Meanwhile, the investigators analyzed the consistency of the results obtained from various 21-gene test kits and immunohistochemistry detection.

Conditions

• Relationship and Consistency Analysis

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	recurrence risk evaluation	Recurrence score were obtained by 21-gene detection kits from different biological companies. The expression of ER, PR, and Her-2 were also detected by IHC.

Timeline

• Start date: 2019-01-01
• Primary completion: 2019-01-20
• Completion: 2019-02-01
• First posted: 2019-02-15
• Last updated: 2019-02-15

Locations

1 site across 1 country: China